Enanta Pharmaceuticals Inc (ENTA)
SG&A Expenses
$37.75M
TTM · Period ending: · USD
ENTA SG&A Expenses
Latest reported$37.75Mperiod ending
Latest reported$37.75Mperiod ending
ENTA TTM SG&A Expenses ($5.28M → $37.75M)
TTM SG&A Expenses
High-resolution chart · PNG
ENTA sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 37,748,000 | |
| 38,276,000 | |
| 40,096,000 | |
| 43,933,000 | |
| 47,914,000 | |
| 51,331,000 | |
| 54,178,000 | |
| 57,850,000 | |
| 57,962,000 | |
| 57,166,000 | |
| 56,169,000 | |
| 51,836,000 | |
| 49,955,000 | |
| 49,550,000 | |
| 46,788,000 | |
| 44,111,000 | |
| 40,553,000 | |
| 36,817,000 | |
| 34,667,000 | |
| 32,536,000 | |
| 30,908,000 | |
| 29,254,000 | |
| 27,812,000 | |
| 27,356,000 | |
| 26,791,000 | |
| 26,119,000 | |
| 26,015,000 | |
| 26,246,000 | |
| 25,913,000 | |
| 25,897,000 | |
| 24,823,000 | |
| 23,441,000 | |
| 22,729,000 | |
| 21,827,000 | |
| 21,582,000 | |
| 20,749,000 | |
| 20,071,000 | |
| 19,120,000 | |
| 18,085,000 | |
| 16,966,000 | |
| 16,219,000 | |
| 15,580,000 | |
| 14,592,000 | |
| 13,543,000 | |
| 12,611,000 | |
| 11,571,000 | |
| 10,698,000 | |
| 10,016,000 | |
| 9,005,000 | |
| 8,190,000 | |
| 6,967,000 | |
| 6,032,000 | |
| 6,054,000 | |
| 5,411,000 | |
| 5,276,000 | |
| 5,375,000 | |
| 4,805,000 |